metformin has been researched along with Pneumonia, Bacterial in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Persons with type 2 diabetes (T2D) have neutrophil dysfunction with a higher risk of infection than those without diabetes." | 5.72 | Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes. ( Hsu, CC; Hwu, CM; Shih, YH; Wei, JC; Yen, FS, 2022) |
| "Persons with type 2 diabetes (T2D) have neutrophil dysfunction with a higher risk of infection than those without diabetes." | 1.72 | Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes. ( Hsu, CC; Hwu, CM; Shih, YH; Wei, JC; Yen, FS, 2022) |
| " Metformin use also exhibited significant dose-response relationship with respect to the risks of bacterial pneumonia, hospitalization for COPD and IMV." | 1.56 | Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease. ( Hsu, CC; Hwu, CM; Wei, JC; Yang, YC; Yen, FS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yen, FS | 2 |
| Wei, JC | 2 |
| Shih, YH | 1 |
| Hsu, CC | 2 |
| Hwu, CM | 2 |
| Yang, YC | 1 |
2 other studies available for metformin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Incidence; Metformin; Middle Aged; Pneumonia | 2022 |
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hypoglyc | 2020 |